Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $31.70 USD
Change Today -0.33 / -1.03%
Volume 79.8K
FWP On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

forward pharma a/s-adr (FWP) Snapshot

Open
$32.99
Previous Close
$32.03
Day High
$34.50
Day Low
$31.67
52 Week High
04/27/15 - $34.50
52 Week Low
10/15/14 - $15.75
Market Cap
1.5B
Average Volume 10 Days
81.1K
EPS TTM
--
Shares Outstanding
45.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for FORWARD PHARMA A/S-ADR (FWP)

forward pharma a/s-adr (FWP) Related Bloomberg News

View More Bloomberg News

forward pharma a/s-adr (FWP) Related Businessweek News

No Related Businessweek News Found

forward pharma a/s-adr (FWP) Details

Forward Pharma A/S operates as a biopharmaceutical company. The company engages in developing FP187, a proprietary formulation of dimethyl fumarate, which has been completed Phase II clinical trials used for the treatment of various inflammatory and neurological indications, including multiple sclerosis and other immune disorders, such as psoriasis. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.

10 Employees
Last Reported Date: 03/25/15
Founded in 2005

forward pharma a/s-adr (FWP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

forward pharma a/s-adr (FWP) Key Developments

Forward Pharma Announces Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

Forward Pharma announced consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported net loss of $2 million or $1.01 loss per share, compared with the prior-year period's $11 million or $0.38 loss per share. This quarter benefited from a $5.6 million net exchange rate gain while fourth quarter 2013 included a $8.8 million expense in connection with the fair value adjustment for shareholder warrants. The company did not record revenue for the quarter, as expected. For the year, the company reported net loss of $19.01 million against $15.696 million a year ago. Basic and diluted per share was $1.79 against $0.54 a year ago.

Forward Pharma A/S Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 10:30 AM

Forward Pharma A/S Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 10:30 AM. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States. Speakers: Joel D. Sendek, Chief Financial Officer.

Forward Pharma A/S Presents at RBC Capital Markets Healthcare Conference 2015, Feb-24-2015 08:30 AM

Forward Pharma A/S Presents at RBC Capital Markets Healthcare Conference 2015, Feb-24-2015 08:30 AM. Venue: The New York Palace Hotel, New York, New York, United States. Speakers: Joel D. Sendek, Chief Financial Officer.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FWP:US $31.70 USD -0.33

FWP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FWP.
View Industry Companies
 

Industry Analysis

FWP

Industry Average

Valuation FWP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 6.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FORWARD PHARMA A/S-ADR, please visit www.forward-pharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.